Search clinical trials for: N 0437

Total 1982 results

Medical University of South Carolina
National Institute of Neurological Disorders and Stroke (NINDS)

Completed

Safety of N-acetylcysteine in Maternal Chorioamnionitis (NAC in Chorio)

Brain Injury | Chorioamnionitis

United States
National Jewish Health
American Thoracic Society

Completed

The Effect of N-Acetyl-L-Cysteine, on Inflammatory and Oxidative Stress Markers in Pulmonary Sarcoidosis

Pulmonary Sarcoidosis

United States
University of Texas Southwestern Medical Center
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Terminated

Study of N-Acetylcysteine in Acute Liver Failure (ALF) (ONAC)

Acute Liver Failure | Fulminant Hepatic Failure

United States
University of California, Los Angeles

Unknown

N-Acetyl Cysteine Protects Pulpal Stem Cells in Endodontic Revascularization (NAC)

Endodontic Disease

United States
Weill Medical College of Cornell University
National Institute on Aging (NIA)

Completed

N-Acetylcysteine for Neuroprotection in Parkinson's Disease (NAC for PD)

Parkinson Disease

United States
Queen's University

Completed

Effects of N-acetylcysteine on Cardiorespiratory Control in COPD Patients With Mild-to-moderate Airflow Obstruction

Pulmonary Disease, Chronic Obstructive
Beth Israel Deaconess Medical Center
Center de Neurosciences Psychiatrique, Lausanne, Switzerland

Completed

N-Acetyl-Cysteine (NAC) in Early Phase Schizophrenia Spectrum Psychosis (NACPSY)

Schizophrenic Psychoses

United States
National University Hospital, Singapore

Completed

COmbined N-acetylcysteine and Bicarbonate in PCI To Reduce Adverse Side Effect of contrasT (CONTRAST)

Contrast Induced Nephropathy

Singapore
University Hospital, Antwerp

Completed

Pilot Study to Assess the Effect of High Dose N-acetylcysteine (NAC) in Chronic Obstructive Pulmonary Disease (COPD) Patients

COPD

Belgium
Medical University of Gdansk

Completed

Optimalization of Nephroprotection Using N-Acetylcysteine

Proteinuria | Chronic Kidney Disease
Michio Hirano, MD
United States Department of Defense

Recruiting

Study of N-acetylcysteine in the Treatment of Patients With the m.3243A>G Mutation and Low Brain Glutathione Levels

Mitochondrial Disease

United States
Centre for Addiction and Mental Health

Recruiting

Effects of NAC on Symptoms of CHR Patients

Prodromal Schizophrenia

Canada
CareFusion

Completed

Evaluating Safety and Effectiveness of Octenidine Dihydrochloride

Preoperative Skin Preparation

United States
Yale University

Completed

N-acetylcysteine (NAC) for Pediatric Obsessive-Compulsive Disorder

Obsessive-Compulsive Disorder

United States
University of Minnesota
Parkinson's Disease Society of the United Kingdom

Completed

Repeated-Dose Oral N-acetylcysteine for the Treatment of Parkinson's Disease

Parkinson Disease

United States
Medical University of South Carolina
National Institute on Drug Abuse (NIDA)

Completed

Achieving Cannabis Cessation-Evaluating N-Acetylcysteine Treatment (ACCENT)

Cannabis Dependence

United States
King's College London

Completed

Effect of N-acetylcysteine on Brain Glutamate (NAC)

Psychosis

United Kingdom
Yale University
American Academy of Child Adolescent Psychiatry.

Completed

N-acetylcysteine (NAC) for Children With Tourette Syndrome

Tic | Tourettes Syndrome

United States
Yale University
Trichotillomania Learning Center

Completed

N-Acetylcysteine for Pediatric Trichotillomania

Trichotillomania | Hair Pulling

United States
University of Washington
National Institutes of Health (NIH)

Completed

Effect of Diesel Exhaust Particulate Exposures on Endothelial Function in Humans

Healthy

United States
TC Erciyes University

Completed

Protective Effect of N-acetylcysteine Against From Ototoxicity

Hearing Loss, Extreme

Turkey
Far Eastern Memorial Hospital
Synmosa Biopharma Corp.

Suspended

Acetylcysteine Against Acute Renal Insult During Cardiopulmonary Bypass.

Cardiovascular Disease | Cardiopulmonary Bypass | Renal Insufficiency, Acute

Taiwan
Bayside Health
The Alfred

Unknown

N-Acetylcysteine in Heart Failure With Coexistent Chronic Renal Failure

Kidney Failure, Chronic | Heart Failure, Congestive

Australia
University of Milan

Completed

Contrast Nephropathy Prevention With N-Acetylcysteine in Acute Myocardial Infarction

Acute Myocardial Infarction | Contrast-Induced Nephropathy

Italy
National Cancer Institute (NCI)

Completed

O6-Benzylguanine and Topical Carmustine in Treating Patients With Early-Stage IA-IIA Cutaneous T-Cell Lymphoma

Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | Stage I Mycosis Fungoides and Sezary Syndrome AJCC v7 | Stage II Mycosis Fungoides and Sezary Syndrome AJCC v7

United States
Asian Institute of Gastroenterology, India

Completed

Pre-medication With N-acetylcysteine and Simethicone to Improve Mucosal Visibility During Gastroduodenoscopy (SIMETHICONE)

Mucosal Erosion

India
Xiyuan Hospital of China Academy of Chinese Medical...

Recruiting

Study to Evaluate the Efficacy, Safety and Tolerability of Photodynamic Therapy(PDT) With Chlorin-e6 in Treating Moderate to Severe Acne

Acne | Photodynamic Therapy

China
Haukeland University Hospital
Western Norway University of Applied Sciences

Recruiting

Edinburgh Cognitive and Behavioural Amyotrophic Lateral Sclerosis Screen in Norway: A Prospective Cohort Study

Cognitive Impairment | Amyotrophic Lateral Sclerosis

Norway
Mansoura University

Completed

Clinical Performance of Dual- and Light-cure Bulk-fill Resin Composites

Dental Caries Class II

Egypt
Instituto Nacional de Ciencias Medicas y Nutricion...

Completed

Effect of Parenteral Nutrition With n-3 PUFAs on Patients With Intestinal Failure

Intestinal Failure

Mexico
China Medical University Hospital
National Science Council, Taiwan

Completed

Omega-3 Polyunsaturated Fatty Acids on Major Depressive Disorder in Patients With Cardiovascular Diseases

Cardiovascular Diseases | Major Depressive Disorder

Taiwan
China Medical University Hospital
King's College London; National Science Council, Taiwan

Completed

Omega-3 Polyunsaturated Fatty Acids in Youth With ADHD

ADHD | Attention Deficit Hyperactivity Disorder

Taiwan
Federal University of Rio Grande do Sul

Completed

n-3 Fatty Acid Effects in T2DM After Acute High Intensity Exercise

Type2 Diabetes Mellitus

Brazil
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Antiarrhythmic Effects of N-3 Fatty Acids

Heart Diseases | Arrhythmia | Ventricular Fibrillation | Tachycardia, Ventricular
ASIS Corporation

Unknown

ASIS for Enbrel in Plaque Psoriasis (ASISinPP)

Plaque Psoriasis.

United States
Cairo University

Not yet recruiting

Clinical and Radiographic Evaluation of Alkasite Restorative Material Versus Glass Ionomer Cement (GIC)

Tooth Decay
National Cancer Institute (NCI)

Recruiting

Phase I/II Study of the Combination Immunotherapy Regimen: SX-682, TriAdeno Vaccine, Retifanlimab and IL-15 Agonist N-803 (STAR15) for Metastatic Colorectal Cancer (mCRC)

Metastatic Colorectal Cancer

United States
Leiden University Medical Center

Completed

Reducing Aggression Among People With an Intellectual Disability (PSYVB)

Aggression | Intellectual Disability

Netherlands
Sun Yat-sen University

Unknown

Effects and Mechanisms of n-3 PUFAs and Irisin on Abnormal Glucose Metabolism After GDM.

Gestational Diabetes Mellitus

China
Psychiatric University Hospital, Zurich
Swiss Federal Institute of Technology; Zurich Center for Integrative Human... and other collaborators

Completed

Neurobiological Adaptations and Pharmacological Interventions in Cocaine Addiction (CoGlu)

Cocaine Addiction

Switzerland
BioMarin Pharmaceutical

Completed

A Phase 4 Two Dose Level Study of Naglazyme(TM) (Galsulfase) in Infants With MPS VI

Mucopolysaccharidosis VI | Maroteaux-Lamy Syndrome

United States, Portugal, France
Fundacion GESICA

Unknown

Randomized Trial to Assess Efficacy of PUFA for the Maintenance of Sinus Rhythm in Persistent Atrial Fibrillation (FORWARD)

Atrial Fibrillation

Argentina
Fudan University

Recruiting

Effect of Butyphthalide on Cognitive Level Change After Cerebral Vascular Event-a Randomized Control Trial (Be-CLEVER) (Be-CLEVER)

Stroke | Post-stroke Cognitive Impairment (PSCI)

China
Rijnstate Hospital

Terminated

N-AcetylCysteine vs. Placebo to Prevent Neurotoxicity Induced by Platinum Containing Chemotherapy (NAC-PNP)

Carcinoma, Non-Small-Cell Lung | Mesothelioma | Carcinoma, Small Cell Lung

Netherlands
The University of Texas Health Science Center,...
National Institutes of Health (NIH)

Completed

Hypertrophic Regression With N-Acetylcysteine in HCM (HALT)

Hypertrophic Cardiomyopathy

United States
University of California, San Francisco
National Heart, Lung, and Blood Institute (NHLBI)

Terminated

Inpatient Clinical Trial of NAC (ICON)

Asthma

United States
Yale University

Terminated

N-Acetylcysteine Augmentation in Treatment-Refractory Obsessive-Compulsive Disorder

Obsessive-Compulsive Disorder
Beni-Suef University

Completed

The Effect of N-acetylcysteine on Oxidative Stress Status and Iron Overload in Thalassemia Major

Thalassemia Major

Egypt
University of Minnesota
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National... and other collaborators

Completed

Intravenous N-acetylcysteine for the Treatment of Gaucher's Disease and Parkinson's Disease

Parkinson's Disease | Gaucher's Disease

United States
Assiut University

Completed

Supportive Measures in Treatment of Aluminum Phosphide Poisoning

Detection of Different Prognostic Factors and Their Relation With the Outcome | Using New Protocol to Prove the Role of N-acetyl Cysteine and Adequate Supportive Measures in Aluminum Phosphide Poisoning

Search clinical trials for: N 0437

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kyrgyzstan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations